Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1

Nature Medicine

Volumn 4, Issue 8, 1998, Pages 953-956

  Komanduri, Krishna V ^a,b   Viswanathan, Mohan N ^a   Wieder, Eric D ^a   Schmidt, Diane K ^a   Bredt, Barry M ^b   Jacobson, Mark A ^b   McCune, Joseph M ^a,b  

^a GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GANCICLOVIR;

ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOMEGALOVIRUS; FLOW CYTOMETRY; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; PRIORITY JOURNAL; RETINITIS; VIRUS REPLICATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COHORT STUDIES; CYTOMEGALOVIRUS RETINITIS; FLOW CYTOMETRY; GANCICLOVIR; HIV-1; HUMANS; LONGITUDINAL STUDIES; LYMPHOCYTE ACTIVATION;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031881026     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0898-953     Document Type: Article

References (20)

1. + repertoire during antiviral therapy. Nature Med. 4, 215-221 (1998).
2. + T cell homeostasis and function in advanced HIV disease. Science 277, 112-116 (1997).
3. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nature. Med. 3, 533-540 (1997).
4. Jacobson, M.A. Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 337, 105-114 (1997).
5. Cunningham, E.T. & Margolis, T.P. in Duane's Fundamentals of Clinical Ophthalmology Vol. 2 (36) (ed. Tasman, W.) 1-36 (Lippincott-Raven, Philadelphia, 1998).
6. Holland, G.N., Gottlieb, M.S., Yee, R.D., Schanker, H.M. & Pettit, T.H. Ocular disorders associated with a new severe acquired cellular immunodeficiency syndrome. Am. J. Ophthalmol. 93, 393-402 (1982).
7. Krause, H., Hebart, H., Jahn, G., Muller, C.A. & Einsele, H. Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease. Bone Marrow Transplant. 19, 1111-1116 (1997).
8. + T-cell clones specifically activated by IE1 peptides in vitro. J. Virol. 70, 2162-2169 (1996).
9. Ihara, T. et al. Impaired cell-mediated immunity to cytomegalovirus (CMV) in leukemic children with prolonged CMV viruria. Leuk. Res. 18, 485-491 (1994).
10. Alp, N.J. et al. Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein. J. Virol. 65, 4812-4820 (1991).
11. + lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 24, 836-840 (1997).
12. Schrier, R.D., Freeman, W.R., Wiley, C.A. & McCutchan, J.A. Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group. J. Clin. Invest. 95, 1741-1746 (1995).
13. Walter, E.A. et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333, 1038-1044 (1995).
14. + T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J. Clin. Invest. 99, 1739-1750 (1997).
15. Baltimore, D. The enigma of HIV infection. Cell 82, 175-176 (1995).
16. Prussin, C. & Metcalfe, D.D. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J. Immunol. Methods 188, 117-128 (1995).
17. Sabbaj, S. et al. Quantitation of antigen-specific immune responses in human immunodeficiency virus (HIV)-infected individuals by limiting dilution analysis. J. Clin. Immunol. 12, 216-224 (1992).
18. Schulick, R.D., Clerici, M., Dolan, M.J. & Shearer, G.M. Limiting dilution analysis of interleukin-2-producing T cells responsive to recall and alloantigens in human immunodeficiency virus-infected and uninfected individuals. Eur. J. Immunol. 23, 412-417 (1993).
19. Murali-Krishna, K. et al. Counting antigen-specific CDS T cells: a reevaluation of bystander activation during viral infection. Immunity 2, 177-187 (1998).
20. + T cells during an acute virus infection. Immunity 2, 167-175 (1998).